BPC/TB500.

DISCLAIMER: THIS PRODUCT IS INTENDED FOR RESEARCH USE ONLY. THIS PRODUCT IS DESIGNED EXCLUSIVELY FOR LAWFUL IN VITRO LABORATORY RESEARCH AND ANALYTICAL APPLICATIONS. THE INFORMATION PROVIDED ON THIS W...

$57.00

Select Protocol

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for BPC/TB500.

Primary Target

Receptor Binding

This compound interacts with specific receptor sites characterized in published preclinical research models.

Downstream Cascade

Signal Transduction

Published studies have examined downstream signaling effects in cell culture and tissue models.

Transcriptional Regulation

Gene Expression

Research indicates modulation of gene expression profiles in targeted tissue preparations.

Functional Output

Cellular Response

Functional assays in preclinical models have characterized cellular response patterns.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on BPC/TB500 molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of BPC/TB500 in standardized assay systems.

Preclinical

BPC/TB500 structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of BPC/TB500 in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring